You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Passive Wireless Corrosion-Monitoring Tags
SBC: ENGENIUSMICRO LLC Topic: A12aT001EngeniusMicro and the Georgia Institute of Technology propose a passive wireless sensor platform for the monitoring of corrosion on aircraft and for stored aircraft components. Multiple volumes, chambers, and compartments within aircraft are susceptible to corrosion damage because they are exposed to moisture, they trap heat, and they are difficult to inspect. Placing passive wireless corrosion se ...
STTR Phase II 2014 Department of DefenseArmy -
Atomic Layer Deposition of PbZrxTi1-xO3 Thin Films for PiezoMEMS Applications
SBC: STRUCTURED MATERIALS INDUSTRIES, INC. Topic: A12aT020In this STTR program, Structured Materials Industries, Inc. (SMI) and partners will develop hardware and process technology to deposit uniform films of piezoelectric PbZrxTi1-xO3, on substrates with complex 3-dimensional topography. Piezoelectric PbZrxTi1-xO3 films are a critical technology for advanced Micro Electro Mechanical System (MEMS), to provide low power actuation in nanoscale devices. ...
STTR Phase II 2014 Department of DefenseArmy -
NMDA Receptor Subtype Selective Modualtors as Alzheimer's Disease Therapeutics
SBC: NEUROP, INC. Topic: NIADESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a devastating neurodegenerative disorder. One of the few drugs used to treat AD is memantine, which inhibits N-methyl-d-aspartate receptors (NMDARs), glutamate receptor subtypes found at nearly all vertebrate excitatory synapses. NMDARs are critically involved in many aspects of nervous system function, including learning and me ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Enable Early and Sensitive In Vivo Detection of Liver Metastasis by Protein-based
SBC: INLIGHTA BIOSCIENCES L.L.C. Topic: NCIDESCRIPTION (provided by applicant): The major barriers limiting the application of MRI to detect small liver lesions and metastasis at the early stage and patient selection for targeted therapy based on molecular imaging of disease biomarkers, are due tothe lack of desired MRI contrast agents capable of enhancing the contrast between normal liver tissues and tumors with high relaxivity, tumor tar ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics
SBC: PPI PHARMACEUTICALS, LLC Topic: NCIDESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel Antimicrobial Foley Catheter to Prevent CAUTIs
SBC: HYDROMER, INC. Topic: NIDDKDESCRIPTION (provided by applicant): Catheter-associated urinary tract infections (CAUTI) are a leading cause of hospital-acquired infections and lead to increased costs, suffering and mortality. A primary contributor to CAUTI is formation of bacterial biofilms on indwelling catheters. Biofilms are inherently resistant to most antibiotics, and once established serve as a bacterial reservoir propag ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
A Millimeter-wave Tunable Cavity for Ultra-sensitive Solids and Liquids DNP-NMR at Low Budget
SBC: DOTY SCIENTIFIC, INC. Topic: NIA? DESCRIPTION (provided by applicant): NMR is probably the most powerful and widely used analytical technique for structure determination and function elucidation of molecules of all types, but it suffers from low sensitivity, particularly for insoluble biological macromolecules. Dynamic Nuclear Polarization (DNP) with Magic Angle Spinning (MAS) has recently demonstrated S/N gains exceeding t ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Use of EF2K Inhibitors to Reduce Toxicity to Normal Tissues in Chemotherapy
SBC: LONGEVICA PHARMACEUTICALS, INC. Topic: NCIDESCRIPTION (provided by applicant): Eukaryotic elongation factor 2 protein kinase (eEF2K) is a ubiquitously expressed protein that belongs to a family of alpha kinases characterized by an atypical kinase domain. Our recent findings demonstrate that inhibition or genetic inactivation of eEF2K protects normal tissues from cytotoxic effects of chemotherapeutic agents and ionizing radiation. We hav ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Robotic whole organism HTS platform for drug discovery and development
SBC: Luminomics Inc. Topic: NCATSDESCRIPTION (provided by applicant): Our goal is to create a compact, affordable, fully automated, screening system for large-scale drug 2 testing in living small animal disease models (e.g., worms, flies, and fish). Modern drug discovery is 3 driven by high-throughput screening (HTS) systems that have the capacity to evaluate large chemical 4 compound 'libraries'. The majority of hits ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Targeting B-cell lymphoma with Leukothera-phase II
SBC: Actinobac Biomed, Inc. Topic: NCIDESCRIPTION provided by applicant B cell lymphoma is cancer of B lymphocytes and accounts for more than deaths in the U S each year While many patients respond to currently available therapy there is a high rate of cancer relapse and inability for the patients o tolerate chemotherapy Thus there is a significant need to make available to these patients newer therapies that are more e ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health